April 23, 2018
Eijkman Institute congratulates Dodi Safari, PhD for his outstanding achievement in scientific research focusing on Pneumococcal diseases. He received the 2018 Robert Austrian Research Awards for the research project titled "Effect of Pneumococcal Vaccination on The Nasopharyngeal colonization of S. pneumoniae among children above 6 years of age with HIV (Randomized Control Trial)", in a ceremony held during the 11th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD-11), Melbourne 15-19 April 2018.
The awards were given annually to honor the memory of Robert Austrian for his pioneering and immensely important research on pneumococci and pneumococcal diseases. The multi-national pharma company Pfizer is sponsoring research awards in the field of pneumococcal vaccinology. Recipients of the Robert Austrian Research Awards in Pneumococcal Vaccinology were selected from applications and nominations, based on a research proposal and curriculum vitae with a list of publications and a letter of recommendation.
Dr. Safari is one of Eijkman Institute’s Senior Research Fellows and Head of the Molecular Bacteriology Unit in the institute. His research mainly focuses on Epidemiology of Streptococcus pneumoniae in Indonesian population. He also delves in the development of pneumonia vaccine and the study of pneumococcal vaccination impact. When asked about his feeling in receiving the award, Dr. Safari said that he was pleased and honored to accept it. Dr. Safari acknowledged the importance of the award by saying:
“This award is important for my research career on the pneumococcal field and will support our research project on pneumococcal vaccination impact in high risk population in Indonesia.”
To complete his success story, four members of Dr. Safari’s group, namely: Mr. Miftahuddin Majid Khoeri, Ms. Korrie Salsabila, Ms. Wa Ode Dwi Daningrat, and Mr. Wisnu Tafroji, also received travel grants to attend the ISPPD-11 in Melbourne.